Killian S. Hanlon

1.2k citations

16 papers · 782 indexed · 1 hit paper · h-index 12

Sensory Systems top 2%
- Hearing, Cochlea, Tinnitus, Genetics 3
Genetics top 10%
- Virus-based gene therapy research 9
Business and International Management top 10%
Molecular Biology
- CRISPR and Genetic Engineering 7
- RNA Interference and Gene Delivery 6
- Retinal Development and Disorders 4
- RNA regulation and disease 4
- RNA and protein synthesis mechanisms 3
Aging
Oncology
- CAR-T cell therapy research 2

Co-authors: Casey A. Maguire David P. Corey Adrienn Volak Bence György Benjamin P. Kleinstiver Maryna V. Ivanchenko Cole W. Peters Camilla Lööv
Cited by: Sensory Systems Genetics Business and International Management
Journals: Nature Communications (1 paper)Scientific Reports (2 papers)Trends in Pharmacological Sciences (1 paper)
Partner nations: United States Ireland Netherlands

In The Last Decade

Killian S. Hanlon

16 papers receiving 768 citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Killian S. Hanlon

Since Specialization

Citations

This map shows the geographic impact of Killian S. Hanlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Killian S. Hanlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Killian S. Hanlon more than expected).

Fields of papers citing papers by Killian S. Hanlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Killian S. Hanlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Killian S. Hanlon. The network helps show where Killian S. Hanlon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Killian S. Hanlon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Killian S. Hanlon Line = papers co-authored together Killian S. Hanlon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cord Molecular Therapy ·Killian S. Hanlon,Ming Cheng,Roberto Montoro Ferrer,Jae Ryun Ryu,Boram Lee,Demitri de la Cruz,Nikita Patel,Paula Espinoza,Miguel C. Santoscoy,Yi Gong,Carrie Ng,Diane M. Nguyen,Josette Nammour,Sean W. Clark,Vivi M. Heine,Woong Sun,Karen Kozarsky,Casey A. Maguire	2024	6
2	An Engineered Adeno-Associated Virus Capsid Mediates Efficient Transduction of Pericytes and Smooth Muscle Cells of the Brain Vasculature Human Gene Therapy ·Servio H. Ramirez,Jonathan F. Hale,Siobhán McCarthy,Christian L. Lino Cardenas,Kalpani N. Udeni Galpayage Dona,Killian S. Hanlon,Eloïse Hudry,Demitri de la Cruz,Carrie Ng,Sabyasachi Das,Diane M. Nguyen,Josette Nammour,Rachel E. Bennett,Allison M. Andrews,Patricia L. Musolino,Casey A. Maguire	2023	11
3	Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction Pharmaceutics ·Naomi Chadderton,Arpad Palfi,Daniel Maloney,Matthew Carrigan,Laura K. Finnegan,Killian S. Hanlon,Ciara Shortall,Mary O’Reilly,Peter Humphries,Lorraine Cassidy,Paul F. Kenna,Sophia Millington‐Ward,G. Jane Farrar	2023	5
4	Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F Molecular Therapy ·Cole W. Peters,Killian S. Hanlon,Maryna V. Ivanchenko,Eric Zinn,Elizabeth Linarte,Yaqiao Li,Jonathan M. Levy,David R. Liu,Benjamin P. Kleinstiver,Artur A. Indzhykulian,David P. Corey	2023	21
5	The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration Human Gene Therapy ·Adam W. Beharry,Yi Gong,James C. Kim,Killian S. Hanlon,Josette Nammour,Kate Hieber,Florian Eichler,Ming Cheng,Anat Stemmer‐Rachamimov,Konstantina M. Stanković,Duane Bradley Welling,Carrie Ng,Casey A. Maguire	2021	17
6	Delivering AAV to the Central Nervous and Sensory Systems Trends in Pharmacological Sciences ·Cole W. Peters,Casey A. Maguire,Killian S. Hanlon	2021	31
7	AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear Molecular Therapy — Methods & Clinical Development ·Maryna V. Ivanchenko,Killian S. Hanlon,Daniel M. Hathaway,Alex J. Klein,Cole W. Peters,Yaqiao Li,Panos I. Tamvakologos,Josette Nammour,Casey A. Maguire,David P. Corey	2021	47
8	In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery Scientific Reports ·Cort B. Breuer,Killian S. Hanlon,Jeya-shree Natasan,Adrienn Volak,Amine Meliani,Federico Mingozzi,Benjamin P. Kleinstiver,James J. Moon,Casey A. Maguire	2020	25
9	Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor Progression Frontiers in Molecular Biosciences ·Thomas S. van Solinge,Erik R. Abels,Lieke L. van de Haar,Killian S. Hanlon,Sybren L. N. Maas,Rosalie Schnoor,Jeroen de Vrij,Xandra O. Breakefield,Marike L. D. Broekman	2020	10
10	Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochlea Hearing Research ·Maryna V. Ivanchenko,Killian S. Hanlon,Maya K. Devine,Kelly Tenneson,Frederick Émond,J. Lafond,Margaret A. Kenna,David P. Corey,Casey A. Maguire	2020	45
11	Novel 199 base pair NEFH promoter drives expression in retinal ganglion cells Scientific Reports ·Sophia Millington‐Ward,Naomi Chadderton,Megan Berkeley,Laura K. Finnegan,Killian S. Hanlon,Matthew Carrigan,Peter Humphries,Paul F. Kenna,Arpad Palfi,G. Jane Farrar	2020	9
12	Selection of an Efficient AAV Vector for Robust CNS Transgene Expression Molecular Therapy — Methods & Clinical Development ·Killian S. Hanlon,Jonah C Meltzer,Tetyana P. Buzhdygan,Ming J. Cheng,Miguel Sena‐Esteves,Rachel E. Bennett,Timothy Sullivan,Roshanak Razmpour,Yi Gong,Carrie Ng,Josette Nammour,Daniela Maiz,Simon Dujardin,Servio H. Ramirez,Eloïse Hudry,Casey A. Maguire	2019	103
13	High levels of AAV vector integration into CRISPR-induced DNA breaksbreakdown → Nature Communications ·Killian S. Hanlon,Benjamin P. Kleinstiver,Sara P. Garcia,Mikołaj Piotr Zaborowski,Adrienn Volak,Stefan E. Spirig,Alissa Muller,Alexander A. Sousa,Shengdar Q. Tsai,Niclas E. Bengtsson,Camilla Lööv,Martin Ingelsson,Jeffrey S. Chamberlain,David P. Corey,Martin J. Aryee,J. Keith Joung,Xandra O. Breakefield,Casey A. Maguire,Bence György	2019	289
14	Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate Molecular Therapy — Methods & Clinical Development ·Bence György,Elise Meijer,Maryna V. Ivanchenko,Kelly Tenneson,Frederick Émond,Killian S. Hanlon,Artur A. Indzhykulian,Adrienn Volak,K. Domenica Karavitaki,Panos I. Tamvakologos,Mark Vézina,V. K. Berezovskii,Richard T. Born,Maureen T. O’Brien,J. Lafond,Yvan Arsenijévic,Margaret A. Kenna,Casey A. Maguire,David P. Corey	2018	125
15	A Novel Retinal Ganglion Cell Promoter for Utility in AAV Vectors Frontiers in Neuroscience ·Killian S. Hanlon,Naomi Chadderton,Arpad Palfi,Alfonso Blanco,Peter Humphries,Paul F. Kenna,Sophia Millington‐Ward,G. Jane Farrar	2017	24
16	Cell adhesion and neurite extension in response to two proteolytic fragments of laminin Journal of Neuroscience Research ·Sherry L. Rogers,Sally L. Palm,Paul C. Letourneau,Killian S. Hanlon,J B McCarthy,L T Furcht	1988	14

About Killian S. Hanlon

Killian S. Hanlon is a scholar working on Sensory Systems, Genetics and Molecular Biology, having authored 16 papers that have together received 782 indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (7 papers), RNA Interference and Gene Delivery (6 papers), Retinal Development and Disorders (4 papers), RNA regulation and disease (4 papers), Hearing, Cochlea, Tinnitus, Genetics (3 papers), RNA and protein synthesis mechanisms (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Sensory Systems (163 citations), Genetics (325 citations) and Business and International Management (19 citations). Killian S. Hanlon has collaborated with scholars based in United States, Ireland and Netherlands. Frequent co-authors include Casey A. Maguire, David P. Corey, Adrienn Volak, Bence György, Benjamin P. Kleinstiver, Maryna V. Ivanchenko, Cole W. Peters, Camilla Lööv, Niclas E. Bengtsson and Mikołaj Piotr Zaborowski. Their work appears in journals such as Nature Communications, Scientific Reports and Trends in Pharmacological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact